AGEN: 安帝君斯

AGEN新闻

• 11:31 Agenus Receives Marketion Authorization From Armenia For Botvymo To Treat Adult Patients With Microsatellite Stable Metastatic Colorectal Cancer
• 06:57 Reported Saturday, Agenus Says 25% Of Recurrent Ovarian Cancer Patients Treated With BOT+BAL Were Alive And Off All Therapy At Last Follow-Up, With 48% Estimated Three-Year Survival Among Evaluable Patients
• 06:57 据周六报道，Agenus表示，接受BOT+BAL治疗的复发性卵巢癌患者中，25%在最后一次随访时仍存活且已停止所有治疗；在可评估患者中，估计三年生存率为48%。
• 13:03 Agenus To Present Research On Botensilimab, Fc-Enhanced Multifunctional Anti-CTLA-4 Antibody, In Combination With Balstilimab, Anti-PD-1 Antibody, At SITC 2026
• 13:11 Agenus: Hot Times As It Trudges Towards BOT/BAL Submission (NASDAQ:AGEN)
• 18:25 Kodiak Sciences, AMC Entertainment, Agenus And Other Big Stocks Moving Higher On Monday
• 11:58 Rodman & Renshaw Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $19
• 08:03 Agenus Inc. (AGEN) Shareholder/Analyst Call - Slideshow (NASDAQ:AGEN) 2026-09-11
• 07:17 Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
• 12:06 Coty Posts Mixed Q4 Results, Joins Wolfspeed, ATRenew And Other Big Stocks Moving Lower In Thursday’s Pre
• 21:45 Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates
• 12:50 ImmunityBio (IBRX) Reports Q2 Loss, Beats Revenue Estimates
• 14:00 Agenus (AGEN) Earnings Expected to Grow: Should You Buy?
• 17:11 Do Options Traders Know Something About Agenus Stock We Don't?
• 15:57 AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot
• 15:37 Why Is Agenus Stock Falling on Tuesday? - Agenus (NASDAQ:AGEN)